title: Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.
abstract: The biological actions of the endogenous cannabinoid anandamide are terminated by carrier-mediated transport into neurons and astrocytes, followed by enzymatic hydrolysis. Anandamide transport is inhibited by the compound N-(4-hydroxyphenyl)arachidonylamide (AM404). AM404 potentiates several responses elicited by administration of exogenous anandamide, suggesting that it may also protect endogenous anandamide from inactivation. To test this hypothesis, we studied the effects of AM404 on the plasma levels of anandamide using high-performance liquid chromatography/mass spectrometry (HPLC/MS). Systemic administration of AM404 (10 mg kg(-1) intraperitoneal, i.p. ) caused a gradual increase of anandamide in rat plasma, which was significantly different from untreated controls at 60 and 120 min after drug injection. In plasma, both AM404 and anandamide were associated with a plasma protein, which we identified as albumin by non-denaturing polyacrylamide gel electrophoresis. AM404 (10 mg kg(-1), i.p.) caused a time-dependent decrease of motor activity, which was reversed by the cannabinoid CB(1) receptor antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide.hydrochloride (SR141716A, 0.5 mg kg(-1), i.p). These results are consistent with the hypothesis that AM404 inhibits anandamide inactivation in vivo.
authors.affiliation: Department of Pharmacology, University of California, 360 Med Surge II, Irvine, CA 92697-4625, USA. agiuffri@uci.edu
authors.forename: A
authors.initials: A
authors.lastname: Giuffrida
authors.forename: F
authors.initials: F
authors.lastname: Rodriguez de Fonseca
authors.forename: F
authors.initials: F
authors.lastname: Nava
authors.forename: P
authors.initials: P
authors.lastname: Loubet-Lescoulié
authors.forename: D
authors.initials: D
authors.lastname: Piomelli
mesh_terms: D000577:Amides; D000818:Animals; D001095:Arachidonic Acids / Q000097:blood* / Q000737:chemistry / Q000494:pharmacology*; D063388:Endocannabinoids; D004983:Ethanolamines; D008297:Male; D009043:Motor Activity / Q000187:drug effects* / Q000502:physiology; D010169:Palmitic Acids / Q000097:blood / Q000737:chemistry; D053284:Polyunsaturated Alkamides; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000577:Amides; D001095:Arachidonic Acids; D063388:Endocannabinoids; D004983:Ethanolamines; D010169:Palmitic Acids; D053284:Polyunsaturated Alkamides; C005958:palmidrol; C078814:anandamide; C107594:N-(4-hydroxyphenyl)arachidonylamide